Cost-effectiveness of carfilzomib plus dexamethasone...

  • Main
  • 2017 / 10
  • Cost-effectiveness of carfilzomib plus dexamethasone...

Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States

Jakubowiak, Andrzej J., Houisse, Ivan, Májer, István, Benedict, Ágnes, Campioni, Marco, Panjabi, Sumeet, Ailawadhi, Sikander
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Review of Hematology
DOI:
10.1080/17474086.2017.1391088
Date:
October, 2017
File:
PDF, 2.18 MB
english, 2017
Conversion to is in progress
Conversion to is failed